Focus
Attuali politiche vaccinali in Italia per pneumococco, meningococco e varicella
Figli di un dio minore: cosa č cambiato?
CHILDREN OF A MINOR GOD: WHAT HAS CHANGED?
ROSARIO CAVALLO
Pediatra di famiglia, Salice Salentino (Lecce)
Febbraio 2008 - pagg. 87 -92
Abstract
Several “new” vaccines are available nowadays and many other are getting ready. Vaccines are important health tools with a mainly high technological level and have a positive result on the individual protection against a lot of diseases. However, the Public Health level imposes a careful evaluation of the “population” effects which may come from an extensive use of these vaccines or from an interference with vaccination programmes of priority importance. In the region of Puglia (Italy), which adopted active and free heptavalent pneumococcal, meningococcal and chickenpox vaccines for all the new-borns, the cover rates for measles, rubella and mumps vaccines are still insufficient, even if the extraordinary vaccination campaign has been adopted after the measles epidemy in 2002-2003. Therefore, an underlying contradiction is going on: alongside the largest public proposal ever made by an Italian region in the “new” vaccine field, there is still the risk that disastrous epidemic events arising from “old” diseases recur.
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Bibliografia
1. Cavallo R. Figli di un dio minore. Medico e
Bambino 2005;24(1):31-5.
2. Castiglia P, Gallisai D, Sotgiu G, et al. Epidemiology of invasive pneumococcal infections in Sardinian children; poster of ISPPD-4 Helsinki 2004.
3. Romano G, Poli A, Tardivo S, et al. Invasive pneumococcal diseases in age group 0-36 months: results from a perspective surveillance program in Northern-Eastern Italy. Poster of ISPPD-4 Helsinki 2004.
4. D’Ancona F, Salmaso S, Barale A, et al. Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine 2005;23(19):2494-500.
5. www.who.int/wer (WHO-World Health Organization), nel Weekly Epidemiological Record 2007;82(12):93-104.
6. Salmaso S, Caporali MG, Ciofi degli Atti M. Centro Nazionale di Epidemiologia ISS. Comunicazione 0014937 prot. 24/04/2007- 0021327.
7. Byington CL, Samore MH, Stoddard GJ, et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 2005;41(1): 21-9.
8. Calbo E, Diaz A, Canadell E, et al. Spanish pneumococcal infection study network. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect 2006;12(9):867-72.
9. Peters T, Poehling K. Invasive pneumococcal disease: the target is moving. JAMA 2007;297(16):1825-6.
10. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007;297(16):1784-92.
11. Navarro V, Muntaner C, Borrell C, et al. Politics and Health Outcomes. Lancet 2006; 368:1033-7.
12. World Health Organization. Assessing new vaccines for national immunization programs. WHO Regional Office for Western Pacific 2000.
13. Filia A, Brenna A, Panŕ A, Maggio Cavallaro G, Ciofi degli Atti ML. Ricoveri per morbillo in Italia nel 2002: valutazione dell’impatto in termini di salute e di costi. Rapporto Istisan 05/3/2005.
14. Prato R, Caputi G, Tafuri S. OER, giugno 2006:4-8.
15. Prato R, Chironna M, Caputi G, et al. An outbreak of measles in Apulia, Italy, November 2006-January 2007. Euro Surveill 2007; 12(4):E070405.1.
16. Aprile V. OER, giugno 2006:26-9.
2. Castiglia P, Gallisai D, Sotgiu G, et al. Epidemiology of invasive pneumococcal infections in Sardinian children; poster of ISPPD-4 Helsinki 2004.
3. Romano G, Poli A, Tardivo S, et al. Invasive pneumococcal diseases in age group 0-36 months: results from a perspective surveillance program in Northern-Eastern Italy. Poster of ISPPD-4 Helsinki 2004.
4. D’Ancona F, Salmaso S, Barale A, et al. Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine 2005;23(19):2494-500.
5. www.who.int/wer (WHO-World Health Organization), nel Weekly Epidemiological Record 2007;82(12):93-104.
6. Salmaso S, Caporali MG, Ciofi degli Atti M. Centro Nazionale di Epidemiologia ISS. Comunicazione 0014937 prot. 24/04/2007- 0021327.
7. Byington CL, Samore MH, Stoddard GJ, et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 2005;41(1): 21-9.
8. Calbo E, Diaz A, Canadell E, et al. Spanish pneumococcal infection study network. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect 2006;12(9):867-72.
9. Peters T, Poehling K. Invasive pneumococcal disease: the target is moving. JAMA 2007;297(16):1825-6.
10. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007;297(16):1784-92.
11. Navarro V, Muntaner C, Borrell C, et al. Politics and Health Outcomes. Lancet 2006; 368:1033-7.
12. World Health Organization. Assessing new vaccines for national immunization programs. WHO Regional Office for Western Pacific 2000.
13. Filia A, Brenna A, Panŕ A, Maggio Cavallaro G, Ciofi degli Atti ML. Ricoveri per morbillo in Italia nel 2002: valutazione dell’impatto in termini di salute e di costi. Rapporto Istisan 05/3/2005.
14. Prato R, Caputi G, Tafuri S. OER, giugno 2006:4-8.
15. Prato R, Chironna M, Caputi G, et al. An outbreak of measles in Apulia, Italy, November 2006-January 2007. Euro Surveill 2007; 12(4):E070405.1.
16. Aprile V. OER, giugno 2006:26-9.
Corrispondenza: cavallorosario@alice.it